Rx-info Ltd
- Clinical Services and Training
- Government, Public Health, Not-for-profit, and Support Organisations
- Homecare and Specialised Pharmacy Services
- IT and Software
Rx-info develops software for NHS Hospital Trust pharmacies, including Mental Health and Specialist Trusts, and finance departments, providing them with instant access to high quality business intelligence reports around Medicines from Procurement, to Stock and Issues.
We understand the importance of clear timely information and our software is designed to provide Pharmacy with the ability to analyse Contract adherence, short supply medicine availability and medicines usage.
We work with you to understand your specific needs, install appropriate software and provide personal, follow-up support to your team.
Address
George Bidder BuildingScience Park Centre, 4 Babbage Way
Exeter
EX5 2FN
United Kingdom
Contact Exhibitor
-
The annual NHS drugs bill now exceeds £16 billion, and is growing at a rate of 15 per cent a year. Rx-info’s Define software is the pre-eminent tool in helping hospitals analyse their medicines expend ...
-
Medicines shortages are a continual challenge to pharmacy and having early warning of shortages or stock depletion is invaluable and possible through Exend. Additionally the system can report upon Pr ...
-
Refine software runs on the same data platform as Define, but while Define looks externally to create prescribing and spending comparisons with peer organisations, Refine enables drug usage to be moni ...
-
ADIoS - Abusable Drug Investigational Software - Assists Accountable Officers and Medicine Safety Officers to monitor drugs and locations where diversion may potentially be taking place within the Tru ...
-
Involve is a shared decision-making tool for optimising high cost and biologic prescribing, it adds the key factor of cost effectiveness into the prescribing setting to support ICS budgets
-
EmBox enables a Trust to track expiry dates and batch numbers for Emergency Boxes to recall any with items due to expire or require a manufactures recall.
-
With the release of several Ustekinumab biosimilars in the last months we have added new reports to the ‘Biosimilars’ node in Define and Refine. As with other biosimilar roll outs, we can easily repor ...
-
In response to MHRA inspection requirements that NHS Trusts should have a system to monitor changes in usage trends of GLP-1 agonists to identify diversion, Rx-info has added Semaglutide and Liragluti ...
-
Rx-info is delighted to announce that NICE have access to hospital medicines data to assist with their scoping work. An agreement between NHS England and NICE has provided access to Rx-info Define sec ...